Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Resveratrol activates the Nrf2 pathway in human skin, significantly increasing the production and distribution of the antioxidant glutathione.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Keratinocytes grew and migrated into hair follicle areas but disappeared after 15-20 days.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

In 2002, hair restoration improved by using a different area for grafts and absorbable sutures, leading to less discomfort and better results.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Human-induced stem cell-created skin models can help understand skin diseases by studying the skin's layers.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Skin treatment can lower life quality for patients with skin conditions.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Skin changes can indicate a risk for breast cancer.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Insulin resistance significantly contributes to the development and severity of certain chronic skin diseases.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Injecting specific cells into the skin can help improve skin structure and reduce blisters in a genetic skin disorder.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.